logo
Skip Navigation Links Home        Webinars & Training        New & Notable        News Item Details
Print Share This Page

News Item Details

Jun 30, 2017

Supreme Court of Canada decision: Patent Doctrine


The Supreme Court of Canada released the following decision:

AstraZeneca Canada Inc. v. Apotex Inc., 2017 SCC 36, File no. 36654

(Intellectual property — Patents — Medicines — Validity — Pharmaceutical patent invalidated for want of utility on basis of promise of patent doctrine — Whether doctrine is correct approach to determine whether invention has sufficient utility under s. 2  of Patent Act  — Whether drug for which pharmaceutical patent was granted is “useful” within meaning of s. 2  of Patent Act  at filing date — Patent Act, R.S.C. 1985, c. P‑4, s. 2  “invention”.)
Back

Search

Search the News Archives

Need Help?

Found a broken link? Our New & Notable feed is intended to be a current awareness service. Over time, links to external sites may change. If a link doesn't work, try searching the internet for the page or document you're looking for. Or, you can contact us and we'll help you find it.  

Please Upgrade Your Browser

This site's design is only visible in a graphical browser that supports web standards, but its content is accessible to any browser or Internet device.